Biotech stocks have fallen to earth with a thud in 2021 after soaring last year amid excitement over the development of Covid-19 vaccines, dealing big losses to some hedge funds.
The sector is being buffeted by concerns Congress will move to put a lid on drug pricing and a surfeit of early-stage biotech shares as the IPO market booms.
Studying Time: 2 minutes Trisha Paytas has welcomed her third little one. The well-known YouTuber has additionally revealed their unorthodox…
FREMONT — Southbound lanes of Interstate 680 might be closed to visitors…
We independently consider all advisable services. Any services or products put ahead…
At 6:56 a.m. on Wednesday, the Nationwide Climate Service issued…
